Ms Lisa Dubé
Deputy Chief Executive Officer and Company Secretary
Ms Lisa Dubé was promoted to the role of Deputy Chief Executive Officer in December 2019 after joining Cancer Therapeutics in February 2018 in the role of Business Manager and Company Secretary.
Lisa has extensive experience in research and management including finance and quality control. Prior to joining the CRC, Lisa held the position of Business Manager for the CRC for Mental Health and managed the research and commercialisation of mental health biomarkers. Lisa has held senior positions overseas and within Australia at the Burnet Institute, the Walter and Eliza Hall Institute and the Australian Genome Research Facility.
Lisa has a BSc in Biochemistry, an MBA from the University of Victoria, Canada and is a graduate of the Australian Institute of Company Directors.